Metlife Inc. buy UBS Group AG
Summary
This prediction is currently active. With a performance of 8.25%, the BUY prediction by UBS_Group_AG for Metlife Inc. is trending in the right direction. A total of €1.49 was paid as dividends for this prediction. This prediction currently runs until 10.01.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Metlife Inc. | 1.072% | 1.072% |
iShares Core DAX® | 1.056% | 1.056% |
iShares Nasdaq 100 | -1.886% | -0.160% |
iShares Nikkei 225® | 2.553% | 4.359% |
iShares S&P 500 | -0.434% | 0.224% |
Comments by UBS_Group_AG for this prediction
In the thread Metlife Inc. diskutieren